miR‐9 modulates and predicts the response to radiotherapy and EGFR inhibition in HNSCC
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
miR‐9 modulates and predicts the response to radiotherapy and EGFR inhibition in HNSCC ; day:01 ; month:06 ; year:2021 ; extent:20
EMBO molecular medicine / European Molecular Biology Organization ; (01.06.2021) (gesamt 20)
- Urheber
-
Citron, Francesca
Segatto, Ilenia
Musco, Lorena
Pellarin, Ilenia
Rampioni Vinciguerra, Gian Luca
Franchin, Giovanni
Fanetti, Giuseppe
Miccichè, Francesco
Giacomarra, Vittorio
Lupato, Valentina
Favero, Andrea
Concina, Isabella
Srinivasan, Sanjana
Avanzo, Michele
Castiglioni, Isabella
Barzan, Luigi
Sulfaro, Sandro
Petrone, Gianluigi
Viale, Andrea
Draetta, Giulio F.
Vecchione, Andrea
Belletti, Barbara
Baldassarre, Gustavo
- DOI
-
10.15252/emmm.202012872
- URN
-
urn:nbn:de:101:1-2021060215015015733156
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Citron, Francesca
- Segatto, Ilenia
- Musco, Lorena
- Pellarin, Ilenia
- Rampioni Vinciguerra, Gian Luca
- Franchin, Giovanni
- Fanetti, Giuseppe
- Miccichè, Francesco
- Giacomarra, Vittorio
- Lupato, Valentina
- Favero, Andrea
- Concina, Isabella
- Srinivasan, Sanjana
- Avanzo, Michele
- Castiglioni, Isabella
- Barzan, Luigi
- Sulfaro, Sandro
- Petrone, Gianluigi
- Viale, Andrea
- Draetta, Giulio F.
- Vecchione, Andrea
- Belletti, Barbara
- Baldassarre, Gustavo
Ähnliche Objekte (12)
EGFR-Inhibition bei simultaner Strahlentherapie in Abhängigkeit der EGFR vIII-Variante bei HNSCC
Radiotherapy plus EGFR inhibitors: synergistic modalities
β2-Adrenergic receptor modulates mitochondrial metabolism and disease progression in recurrent/metastatic HPV(+) HNSCC
EGFR/Ras-induced CCL20 production modulates the tumour microenvironment
Dual anti-HER2/EGFR inhibition synergistically increases therapeutic effects and alters tumor oxygenation in HNSCC
Anti-EGFR-basierte Therapie bei rezidiviertem oder metastasiertem HNSCC : was für einen Unterschied macht das?
Radiotherapy modulates tumor cell fate decisions: a review
Cyclin A1 shows age-related expression in benign tonsils, HPV16-dependent overexpression in HNSCC and predicts lower recurrence rate in HNSCC independently of HPV16
Cyclin A1 shows age-related expression in benign tonsils, HPV16-dependent overexpression in HNSCC and predicts lower recurrence rate in HNSCC independently of HPV16
Postoperative radiotherapy to the neck for pN1 status HNSCC patients after neck dissection
A meta-validated immune infiltration-related gene model predicts prognosis and immunotherapy sensitivity in HNSCC
PSMD9 expression predicts radiotherapy response in breast cancer
EGFR-Inhibition bei simultaner Strahlentherapie in Abhängigkeit der EGFR vIII-Variante bei HNSCC
Radiotherapy plus EGFR inhibitors: synergistic modalities
β2-Adrenergic receptor modulates mitochondrial metabolism and disease progression in recurrent/metastatic HPV(+) HNSCC
EGFR/Ras-induced CCL20 production modulates the tumour microenvironment
Dual anti-HER2/EGFR inhibition synergistically increases therapeutic effects and alters tumor oxygenation in HNSCC
Anti-EGFR-basierte Therapie bei rezidiviertem oder metastasiertem HNSCC : was für einen Unterschied macht das?
Radiotherapy modulates tumor cell fate decisions: a review
Cyclin A1 shows age-related expression in benign tonsils, HPV16-dependent overexpression in HNSCC and predicts lower recurrence rate in HNSCC independently of HPV16
Cyclin A1 shows age-related expression in benign tonsils, HPV16-dependent overexpression in HNSCC and predicts lower recurrence rate in HNSCC independently of HPV16
Postoperative radiotherapy to the neck for pN1 status HNSCC patients after neck dissection
A meta-validated immune infiltration-related gene model predicts prognosis and immunotherapy sensitivity in HNSCC
PSMD9 expression predicts radiotherapy response in breast cancer
EGFR-Inhibition bei simultaner Strahlentherapie in Abhängigkeit der EGFR vIII-Variante bei HNSCC
Radiotherapy plus EGFR inhibitors: synergistic modalities
β2-Adrenergic receptor modulates mitochondrial metabolism and disease progression in recurrent/metastatic HPV(+) HNSCC
EGFR/Ras-induced CCL20 production modulates the tumour microenvironment
Dual anti-HER2/EGFR inhibition synergistically increases therapeutic effects and alters tumor oxygenation in HNSCC
Anti-EGFR-basierte Therapie bei rezidiviertem oder metastasiertem HNSCC : was für einen Unterschied macht das?
Radiotherapy modulates tumor cell fate decisions: a review
Cyclin A1 shows age-related expression in benign tonsils, HPV16-dependent overexpression in HNSCC and predicts lower recurrence rate in HNSCC independently of HPV16
Cyclin A1 shows age-related expression in benign tonsils, HPV16-dependent overexpression in HNSCC and predicts lower recurrence rate in HNSCC independently of HPV16
Postoperative radiotherapy to the neck for pN1 status HNSCC patients after neck dissection
A meta-validated immune infiltration-related gene model predicts prognosis and immunotherapy sensitivity in HNSCC